Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Immunovant, Inc.
Business Segments
Geographic
Research and development tax credit carry forwards
Research and development tax credit carry forwards
Immunovant, Inc.
·
Geographic
·
1 segment
·
Rolls up to
R&D credit carryforward
Breakdown
Segments
United States
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q4 '22
Q4 '23
Q4 '24
Q4 '25
Q4 '26
United States
$6M
$10.8M
$21.2M
$39.2M
$53.7M
Total
—
—
—
—
—